An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials
Publication
, Conference
Conaghan, P; Strand, V; Hunter, D; Kraus, VB; Berenbaum, F; Katz, NP; Lufkin, J; Johnson, JR; Kelley, S; Bodick, N
Published in: Osteoarthritis and Cartilage
April 2017
Duke Scholars
Published In
Osteoarthritis and Cartilage
DOI
ISSN
1063-4584
Publication Date
April 2017
Volume
25
Start / End Page
S432 / S433
Publisher
Elsevier BV
Related Subject Headings
- Arthritis & Rheumatology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 1106 Human Movement and Sports Sciences
- 1103 Clinical Sciences
- 0903 Biomedical Engineering
Citation
APA
Chicago
ICMJE
MLA
NLM
Conaghan, P., Strand, V., Hunter, D., Kraus, V. B., Berenbaum, F., Katz, N. P., … Bodick, N. (2017). An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials. In Osteoarthritis and Cartilage (Vol. 25, pp. S432–S433). Elsevier BV. https://doi.org/10.1016/j.joca.2017.02.747
Conaghan, P., V. Strand, D. Hunter, V. B. Kraus, F. Berenbaum, N. P. Katz, J. Lufkin, J. R. Johnson, S. Kelley, and N. Bodick. “An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials.” In Osteoarthritis and Cartilage, 25:S432–33. Elsevier BV, 2017. https://doi.org/10.1016/j.joca.2017.02.747.
Conaghan P, Strand V, Hunter D, Kraus VB, Berenbaum F, Katz NP, et al. An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials. In: Osteoarthritis and Cartilage. Elsevier BV; 2017. p. S432–3.
Conaghan, P., et al. “An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials.” Osteoarthritis and Cartilage, vol. 25, Elsevier BV, 2017, pp. S432–33. Crossref, doi:10.1016/j.joca.2017.02.747.
Conaghan P, Strand V, Hunter D, Kraus VB, Berenbaum F, Katz NP, Lufkin J, Johnson JR, Kelley S, Bodick N. An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials. Osteoarthritis and Cartilage. Elsevier BV; 2017. p. S432–S433.
Published In
Osteoarthritis and Cartilage
DOI
ISSN
1063-4584
Publication Date
April 2017
Volume
25
Start / End Page
S432 / S433
Publisher
Elsevier BV
Related Subject Headings
- Arthritis & Rheumatology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 1106 Human Movement and Sports Sciences
- 1103 Clinical Sciences
- 0903 Biomedical Engineering